Global Onychomycosis (Tinea Unguium) Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Report ID: GIR2106040452 | Category: Pharma & Healthcare | Pages: 101 | Format: PDF | Published Date: October 22,2021

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Onychomycosis (Tinea Unguium) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Onychomycosis (Tinea Unguium) Drug size is estimated to be USD 3962.6 million in 2026 from USD 3194.9 million in 2020, with a change XX% between 2020 and 2021. The global Onychomycosis (Tinea Unguium) Drug market size is expected to grow at a CAGR of 5.5% for the next five years.

Market segmentation
Onychomycosis (Tinea Unguium) Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Oral Medication
    External Medicine

Market segment by Application, can be divided into
    Age under 18
    Age 18-50
    Age above 50

Market segment by players, this report covers
    Pfizer
    Yangtze River
    Torrent Pharma
    J&J
    Chengdu Brilliant
    Novartis
    Qilu Pharmaceutical
    Xiuzheng Pharmaceutical
    Hubei Hengan
    TARO
    Perrigo
    Galderma pharm
    Zhejiang Deyer
    Valeant Pharma
    Moberg

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Onychomycosis (Tinea Unguium) Drug, with revenue, gross margin and global market share of Onychomycosis (Tinea Unguium) Drug from 2019 to 2021.
Chapter 3, the Onychomycosis (Tinea Unguium) Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Onychomycosis (Tinea Unguium) Drug market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Onychomycosis (Tinea Unguium) Drug research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Onychomycosis (Tinea Unguium) Drug
    1.2 Classification of Onychomycosis (Tinea Unguium) Drug by Type
        1.2.1 Overview: Global Onychomycosis (Tinea Unguium) Drug Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type in 2020
        1.2.3 Oral Medication
        1.2.4 External Medicine
    1.3 Global Onychomycosis (Tinea Unguium) Drug Market by Application
        1.3.1 Overview: Global Onychomycosis (Tinea Unguium) Drug Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Age under 18
        1.3.3 Age 18-50
        1.3.4 Age above 50
    1.4 Global Onychomycosis (Tinea Unguium) Drug Market Size & Forecast
    1.5 Global Onychomycosis (Tinea Unguium) Drug Market Size and Forecast by Region
        1.5.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region, (2016-2021)
        1.5.3 North America Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2016-2026)
        1.5.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2016-2026)
        1.5.6 South America Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Onychomycosis (Tinea Unguium) Drug Market Drivers
        1.6.2 Onychomycosis (Tinea Unguium) Drug Market Restraints
        1.6.3 Onychomycosis (Tinea Unguium) Drug Trends Analysis
2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.1.4 Pfizer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 Yangtze River
        2.2.1 Yangtze River Details
        2.2.2 Yangtze River Major Business
        2.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.2.4 Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Yangtze River Recent Developments and Future Plans
    2.3 Torrent Pharma
        2.3.1 Torrent Pharma Details
        2.3.2 Torrent Pharma Major Business
        2.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.3.4 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Torrent Pharma Recent Developments and Future Plans
    2.4 J&J
        2.4.1 J&J Details
        2.4.2 J&J Major Business
        2.4.3 J&J Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.4.4 J&J Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 J&J Recent Developments and Future Plans
    2.5 Chengdu Brilliant
        2.5.1 Chengdu Brilliant Details
        2.5.2 Chengdu Brilliant Major Business
        2.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.5.4 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Chengdu Brilliant Recent Developments and Future Plans
    2.6 Novartis
        2.6.1 Novartis Details
        2.6.2 Novartis Major Business
        2.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.6.4 Novartis Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Novartis Recent Developments and Future Plans
    2.7 Qilu Pharmaceutical
        2.7.1 Qilu Pharmaceutical Details
        2.7.2 Qilu Pharmaceutical Major Business
        2.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.7.4 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Qilu Pharmaceutical Recent Developments and Future Plans
    2.8 Xiuzheng Pharmaceutical
        2.8.1 Xiuzheng Pharmaceutical Details
        2.8.2 Xiuzheng Pharmaceutical Major Business
        2.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.8.4 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Xiuzheng Pharmaceutical Recent Developments and Future Plans
    2.9 Hubei Hengan
        2.9.1 Hubei Hengan Details
        2.9.2 Hubei Hengan Major Business
        2.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.9.4 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Hubei Hengan Recent Developments and Future Plans
    2.10 TARO 
        2.10.1 TARO Details
        2.10.2 TARO Major Business
        2.10.3 TARO Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.10.4 TARO Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 TARO Recent Developments and Future Plans
    2.11 Perrigo
        2.11.1 Perrigo Details
        2.11.2 Perrigo Major Business
        2.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.11.4 Perrigo Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Perrigo Recent Developments and Future Plans
    2.12 Galderma pharm
        2.12.1 Galderma pharm Details
        2.12.2 Galderma pharm Major Business
        2.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.12.4 Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Galderma pharm Recent Developments and Future Plans
    2.13 Zhejiang Deyer
        2.13.1 Zhejiang Deyer Details
        2.13.2 Zhejiang Deyer Major Business
        2.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.13.4 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Zhejiang Deyer Recent Developments and Future Plans
    2.14 Valeant Pharma
        2.14.1 Valeant Pharma Details
        2.14.2 Valeant Pharma Major Business
        2.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.14.4 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Valeant Pharma Recent Developments and Future Plans
    2.15 Moberg
        2.15.1 Moberg Details
        2.15.2 Moberg Major Business
        2.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Product and Solutions
        2.15.4 Moberg Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Moberg Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Onychomycosis (Tinea Unguium) Drug Players Market Share
        3.2.2 Top 10 Onychomycosis (Tinea Unguium) Drug Players Market Share
        3.2.3 Market Competition Trend
    3.3 Onychomycosis (Tinea Unguium) Drug Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2016-2021)
    4.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2021)
    5.2 Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2026)
    6.2 North America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2026)
    6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country
        6.3.1 North America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2026)
        6.3.2 United States Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        6.3.3 Canada Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        6.3.4 Mexico Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2026)
    7.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2026)
    7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country
        7.3.1 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2026)
        7.3.2 Germany Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        7.3.3 France Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        7.3.5 Russia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        7.3.6 Italy Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2026)
    8.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2026)
    8.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region
        8.3.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Region (2016-2026)
        8.3.2 China Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        8.3.3 Japan Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        8.3.4 South Korea Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        8.3.5 India Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        8.3.7 Australia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2026)
    9.2 South America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2026)
    9.3 South America Onychomycosis (Tinea Unguium) Drug Market Size by Country
        9.3.1 South America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2026)
        9.3.2 Brazil Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        9.3.3 Argentina Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2026)
    10.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2026)
    10.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country
        10.3.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2026)
        10.3.2 Turkey Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
        10.3.4 UAE Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Onychomycosis (Tinea Unguium) Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?